Get started
Author

Patrick Bastian

Observed names: Bastian, P., P Bastian, P. Bastian, P.I. Bastian, PATRICK BASTIAN
OpenAlex ID: A5013475769
618Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci
2005 · P. Bastian, I. Ellinger, et al. · European Urology Supplements · 5
1904 Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients With Lymph Node Metastasis
2012 · Harun Fajkovic, Eugene Cha, et al. · The Journal of Urology · 3
13 Outcomes of Patients With Clinical T1 Grade 3 Bladder Urothelial Cell Carcinoma Treated With Radical Cystectomy
2007 · A. Gupta, M. Nielsen, et al. · European Urology Supplements · 2
Charlson score to predict overall survival and cancer-related death in elderly patients featuring high-risk prostate cancer.
2015 · Guzman Ordaz, Rafael Sanchez-Salas, et al. · Journal of Clinical Oncology · 1
Discrepancy Between Clinical and Pathological Stage: Impact on Prognosis Following Radical Cystectomy
2006 · S. Shariat, G. Palapattu, et al. · European Urology Supplements · 1
Competing Risks Nomogram Predicting the Probability of Bladder Cancer Recurrence After Cystectomy Can Reliably Distinguish Between Tumours Destined to Recur and Patients Who May Die of Other Causes Before Recurrence
2006 · K.F. Chun, A. Briganti, et al. · European Urology Supplements · 1
538 Prediction of cancer-specific survival in patients with radical cystectomy for bladder cancer using artificial neural networks
2015 · P. Nuhn, A. Aziz, et al. · European Urology Supplements
935 Charlson score predicts overall survival and cancer related death in elderly patients featuring high risk prostate cancer
2015 · G. Ordaz Jurado, R. Sánchez Salas, et al. · European Urology Supplements
634 In high-risk prostate cancer, prognostic factors predict cancer related death in a time-dependent fashion following surgery: A multi-institutional competing risk analysis
2014 · L. Tosco, A. Laenen, et al. · European Urology Supplements
638 Combination of postoperative prognostic features to predict cancer specific survival in high-risk prostate cancer: A multi institutional competing risk analysis
2014 · L. Tosco, A. Laenen, et al. · European Urology Supplements
Op3-06 Impact of Time to Biochemical Recurrence on Cancer-specific Mortality in Patients With High-risk Prostate Cancer Treated With Radical Prostatectomy: a Competing-risks Regression Analysis
2014 · Giorgio Gandaglia, Firas Abdollah, et al. · The Journal of Urology
P097 Revision of the definition of high-risk prostate cancer (PCa): cT2c remains an independent risk factor
2013 · T. Van Den Broeck, L. Tosco, et al. · European Urology Supplements
P100 Not all node positive high-risk prostate cancer patients are the same
2013 · T. Van Den Broeck, L. Tosco, et al. · European Urology Supplements
286 Clinical and pathological nodal staging score for urothelial carcinoma of the bladder are valid decision tools for risk assessment and clinical decision-making: An external validation
2013 · M.S. Gierth, H.M. Fritsche, et al. · European Urology Supplements
1400 Clinical Nodal Staging Scores for Bladder Cancer a New Preoperatively Nodal Assessment Tool
2012 · Michael Rink, Behfar Ehdaie, et al. · The Journal of Urology
998 High-risk Prostate Cancer Presenting With Biopsy Gleason Score 8, 9 or 10: Downgrading and Cancer-specific Survival
2012 · Steven Joniau, Martin Spahn, et al. · The Journal of Urology
1906 Positive Surgical Margins Contribute to Delayed Failures in Patients Undergoing Radical Cystectomy for Bladder Cancer
2012 · Edwin Morales, Shahrokh Shariat, et al. · The Journal of Urology
Influence of Gender on Outcome following Radical Cystectomy: A Competing Risk Analysis
2010 · Shahrokh F. Shariat, Colin P. Dinney, et al. · Journal of Men s Health
36 Outcome Prediction in Patients With Bladder Cancer After Cystectomy Using Artificial Neural Networks
2010 · A. Büchner, C. Bolenz, et al. · European Urology Supplements
323 International Validation of the Prognostic Value of Lymphovascular Invasion in Radical Cystectomy Patients
2010 · S.F. Shariat, R. Svatek, et al. · European Urology Supplements
313 Adjuvant Chemotherapy for Urothelial Carcinoma of the Urinary Bladder
2010 · Robert Svatek, Shahrokh Shariat, et al. · The Journal of Urology
Outcome after a failed bulbourethral sling procedure in men with postprostatectomy incontinence and a repeat bulbourethral sling
2009 · Irina Solyanik, Ricarda M. Bauer, et al. · ics.org
Multi-institutional Evaluation of the Predictive Value of P53 Immunohistochemical Staining in Patients With Pt1-2 N0 Disease at Radical Cystectomy
2008 · S. Shariat, Y. Lotan, et al. · European Urology Supplements
A Contribution to the Use of Nomograms as Predictive Tools for Bladder Cancer: There's Still a Long Way to Go
2008 · H.M. Fritsche, M. Burger, et al. · European Urology Supplements
The Effect of Competing Mortality on the Risk of Bladder-cancer Recurrence and Bladder Cancer Specific Survival
2006 · K.h.F. Chun, A. Briganti, et al. · European Urology Supplements
Works count: 35
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type